Janssen Research & Development, LLC Clinical Trial
Janssen Research & Development, LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Janssen Research & Development, LLC Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:33 UTC. Showing 200 of 839. Open this list on ClinicalTrials.gov
- N/ANCT07915232 · A Study to Assess Pregnancy, Neonatal and Infant Outcomes in Participants Exposed to NipocalimabJanssen Research & Development, LLC · not yet recruiting · Pregnancy Related, Pregnancy, Pregnancy High-risk · study director
- Ph3NCT07906717 · A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph3NCT07903272 · A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant EligibleJanssen Research & Development, LLC · not yet recruiting · Multiple Myeloma · study director
- Ph2NCT07832292 · A Study of JNJ-101556143 in Participants With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- N/ANCT07822529 · A Study of Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel DiseaseJanssen Research & Development, LLC · recruiting · Inflammatory Bowel Diseases · study director
- Ph2NCT07746687 · A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe AsthmaJanssen Research & Development, LLC · recruiting · Asthma · study director
- Ph1NCT07746713 · A Study of JNJ-98768111 in Participants With Advanced Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms
- Ph3NCT07716098 · A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant DepressionJanssen Research & Development, LLC · recruiting · Depressive Disorder, Treatment-Resistant · study director
- Ph1NCT07669077 · A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating WomenJanssen Research & Development, LLC · recruiting · Healthy · study director
- Ph3NCT07665450 · A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedJanssen Research & Development, LLC · recruiting · Multiple Myeloma
- Ph4NCT07654751 · A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA TherapeuticallyJanssen Research & Development, LLC · recruiting · Psoriasis, Colitis, Ulcerative, Crohn Disease · study director
- Ph1NCT07615426 · A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With SchizophreniaJanssen Research & Development, LLC · recruiting · Schizophrenia · study director
- N/ANCT07602088 · A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic LeukemiaJanssen Research & Development, LLC · recruiting · Leukemia, Lymphocytic, Chronic, B-Cell · study director
- Ph2NCT07589634 · A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph2NCT07586202 · A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLCJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT07577843 · A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07577856 · A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · recruiting · Colitis, Ulcerative · study director
- Ph3NCT07573176 · A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderJanssen Research & Development, LLC · recruiting · Depressive Disorder, Major · study director
- Ph1NCT07572006 · A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLC · recruiting · Hematologic Neoplasms · study director
- Ph1NCT07524855 · A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast CancerJanssen Research & Development, LLC · recruiting · Metastatic Breast Cancer · study director
- Ph3NCT07518186 · A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph3NCT07499232 · A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07438496 · A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusJanssen Research & Development, LLC · recruiting · Lupus Erythematosus, Systemic · study director
- Ph2NCT07321873 · A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- Ph1NCT07319871 · A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- N/ANCT07309445 · A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United StatesJanssen Research & Development, LLC · recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph1NCT07308132 · A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid MalignanciesJanssen Research & Development, LLC · recruiting · Lymphoma, Non-Hodgkin · study director
- Ph1NCT07295951 · A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute LeukemiaJanssen Research & Development, LLC · completed · Acute Lymphoblastic Leukemia, Acute Leukemias, Acute Myeloid Leukemia · study director
- Ph3NCT07276399 · A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerJanssen Research & Development, LLC · recruiting · Squamous Cell Carcinoma of Head and Neck · study director
- N/ANCT07230691 · A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World SettingJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph2NCT07230860 · A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic DermatitisJanssen Research & Development, LLC · active not recruiting · Dermatitis, Atopic · study director
- Ph1/Ph2NCT07227025 · A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerJanssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT07225946 · A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms, Castration-Resistant · study director
- N/ANCT07220824 · A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World SettingJanssen Research & Development, LLC · recruiting · Arthritis, Psoriatic · study director
- Ph3NCT07217587 · Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia GravisJanssen Research & Development, LLC · recruiting · Myasthenia Gravis · study director
- Ph2/Ph3NCT07196722 · A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · recruiting · Crohn Disease · study director
- Ph3NCT07196748 · A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · active not recruiting · Colitis, Ulcerative · study director
- N/ANCT07194070 · A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global RegistryJanssen Research & Development, LLC · recruiting · Hemolytic Disease of the Fetus and Newborn · study director
- Ph3NCT07164443 · A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Janssen Research & Development, LLC · recruiting · Metastatic Castration-resistant Prostatic Neoplasms · study director
- Ph4NCT07141004 · A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)Johnson & Johnson Private Limited · recruiting · Arthritis, Psoriatic · study director
- Ph1NCT07082920 · A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph3NCT06919965 · A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerJanssen Research & Development, LLC · recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph3NCT06878404 · A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- N/ANCT06877676 · Pre-Approval Expanded Access Study for TAR-200 Treating Physician UseJanssen Research & Development, LLC · approved for marketing · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph3NCT06852222 · A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Janssen Research & Development, LLC · recruiting · Leukemia, Myeloid, Acute · study director
- Ph3NCT06807424 · A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · active not recruiting · Arthritis, Psoriatic · study director
- Ph1/Ph2NCT06800313 · Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Metastatic Prostate Cancer · study director
- Ph2NCT06785012 · A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderJanssen Research & Development, LLC · completed · Depressive Disorder, Major · study director
- Ph1NCT06768489 · A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma, Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis · study director
- Ph3NCT06750094 · A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyJanssen Research & Development, LLC · recruiting · Colorectal Neoplasms · study director
- Ph3NCT06741969 · Nipocalimab in Moderate to Severe Sjogren's DiseaseJanssen Research & Development, LLC · active not recruiting · Sjogrens Syndrome · study director
- Ph2NCT06667076 · A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Janssen Research & Development, LLC · recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT06663332 · A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsJanssen Research & Development, LLC · recruiting · Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic · study director
- Ph1NCT06663319 · A Study of JNJ-89402638 for Metastatic Colorectal and Gastric CancersJanssen Research & Development, LLC · recruiting · Colorectal Neoplasms, Gastrointestinal Neoplasms · study director
- Ph3NCT06662786 · A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerJanssen Research & Development, LLC · recruiting · Colorectal Neoplasms · study director
- Ph1NCT06660563 · A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)Janssen Research & Development, LLC · active not recruiting · Lymphoma, Non-Hodgkin · study director
- Ph1NCT06651229 · A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsJanssen Research & Development, LLC · active not recruiting · Leukemia, Myeloid, Acute, Myelodysplastic Neoplasms · study director
- Ph3NCT06635135 · A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and PleasureJanssen Research & Development, LLC · terminated · Depressive Disorder, Major, Anhedonia · study director
- Ph2/Ph3NCT06635148 · A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)Janssen Research & Development, LLC · recruiting · Geographic Atrophy, Macular Degeneration · study director
- Ph1NCT06618001 · A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsJanssen Research & Development, LLC · completed · Leukemia, Myeloid, Acute, Myelodysplastic Neoplasms · study director
- Ph1NCT06604715 · A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Relapsed or Refractory Multiple Myeloma · study director
- Ph2NCT06577025 · A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph2NCT06550895 · A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph3NCT06533098 · A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Janssen Research & Development, LLC · recruiting · Thrombocytopenia, Neonatal Alloimmune · study director
- Ph1/Ph2NCT06532032 · A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerJanssen Research & Development, LLC · completed · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT06514742 · A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With AticaprantJanssen Research & Development, LLC · terminated · Depressive Disorder, Major, Anhedonia · study director
- Ph2NCT06500884 · A Study to Evaluate Preventive Treatments for GPRC5D-related Oral EventsJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph1NCT06470438 · A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's LymphomaJanssen Research & Development, LLC · active not recruiting · Lymphoma, Non-Hodgkin, Refractory B-Cell NHL, Relapsed B-cell NHL · study director
- Ph3NCT06449651 · A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Janssen Research & Development, LLC · recruiting · Thrombocytopenia, Neonatal Alloimmune · study director
- Ph1NCT06425991 · A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph1/Ph2NCT06385080 · A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerJanssen Research & Development, LLC · recruiting · Squamous Cell Carcinoma of Head and Neck · study director
- Ph3NCT06260163 · A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · active not recruiting · Colitis, Ulcerative · study director
- Ph1NCT06255665 · A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid TumorsJanssen Research & Development, LLC · completed · Advanced Stage Solid Tumors · study director
- Ph3NCT06211764 · A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)Janssen Research & Development, LLC · active not recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph3NCT06208150 · A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Early Ph1NCT06194578 · A Study of Sterile Saline Infusion in Healthy VolunteersJanssen Research & Development, LLC · completed · Healthy Volunteers · study director
- Ph1NCT06178614 · A Study of JNJ-87890387 for Advanced Solid TumorsJanssen Research & Development, LLC · recruiting · Neoplasms, Advanced Solid Tumors · study director
- Ph1NCT06150157 · A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsJanssen Research & Development, LLC · recruiting · Neoplasms · study director
- Ph1NCT06139406 · A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) CancerJanssen Research & Development, LLC · active not recruiting · Lymphoma, Non-Hodgkin · study director
- Ph3NCT06134804 · A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or OlderJanssen Research & Development, LLC · completed · Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
- Ph2NCT06120140 · Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibJanssen Research & Development, LLC · active not recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph1NCT06095089 · A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerJanssen Research & Development, LLC · recruiting · Prostatic Neoplasms · study director
- Ph3NCT06095102 · A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)Janssen Research & Development, LLC · active not recruiting · Plaque Psoriasis · study director
- Ph3NCT06095115 · A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque PsoriasisJanssen Research & Development, LLC · active not recruiting · Plaque Psoriasis · study director
- Ph2NCT06083753 · Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple SclerosisJanssen Research & Development, LLC · completed · Relapsing Remitting Multiple Sclerosis · study director
- Ph2NCT06049017 · A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · completed · Colitis, Ulcerative · study director
- Ph3NCT06039189 · Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque PsoriasisJanssen Research & Development, LLC · completed · Moderate Plaque Psoriasis · study director
- Ph2NCT06028438 · A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid ArthritisJanssen Research & Development, LLC · completed · Arthritis, Rheumatoid · study director
- Ph2NCT05963074 · A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaJanssen Research & Development, LLC · active not recruiting · Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma · study director
- N/ANCT05957276 · Global Patient Registry of Inherited Retinal DiseasesJanssen Research & Development, LLC · completed · Inherited Retinal Diseases · study director
- Ph3NCT05912517 · A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)Janssen Research & Development, LLC · recruiting · Hemolytic Disease of the Fetus and Newborn · study director
- Ph1/Ph2NCT05908734 · A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerJanssen Research & Development, LLC · active not recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph1NCT05896683 · A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph1NCT05884242 · A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin ChallengeJanssen Research & Development, LLC · completed · Healthy · study director
- Ph3NCT05884398 · A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCJanssen Research & Development, LLC · active not recruiting · Metastatic Castrate-sensitive Prostate Cancer · study director
- N/ANCT05841030 · A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)Janssen Research & Development, LLC · completed · Depressive Disorder, Major · study director
- Ph1NCT05827874 · A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph1NCT05818683 · A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerJanssen Research & Development, LLC · recruiting · Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer · study director
- Ph2NCT05811351 · A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)Janssen Research & Development, LLC · completed · Geographic Atrophy · study director
- Ph1NCT05784441 · A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)Janssen Research & Development, LLC · active not recruiting · Relapsed or Refractory B Cell Non-Hodgkin Lymphoma · study director
- Ph3NCT05784129 · A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical ResectionJanssen Research & Development, LLC · terminated · Crohn's Disease · study director
- N/ANCT05757973 · Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · approved for marketing · Relapsed or Refractory Multiple Myeloma · study director
- Ph3NCT05757869 · A Study of Milvexian Versus Apixaban in Participants With Atrial FibrillationJanssen Research & Development, LLC · active not recruiting · Atrial Fibrillation · study director
- Ph3NCT05754957 · A Study of Milvexian in Participants After a Recent Acute Coronary SyndromeJanssen Research & Development, LLC · completed · Acute Coronary Syndrome · study director
- Ph3NCT05714202 · A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)Janssen Research & Development, LLC · active not recruiting · Bladder Cancer · study director
- Ph1NCT05703841 · A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph3NCT05702034 · A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKEJanssen Research & Development, LLC · active not recruiting · Ischemic Stroke; Ischemic Attack, Transient · study director
- Ph2NCT05663866 · Premedication to Reduce Amivantamab Associated Infusion Related ReactionsJanssen Research & Development, LLC · active not recruiting · Carcinoma, Non-Small-Cell Lung · study director
- N/ANCT05661604 · A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe IllnessJanssen Research & Development, LLC · completed · Acute Respiratory Viral Infection · study director
- Ph2NCT05653427 · A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular CarcinomaJanssen Research & Development, LLC · terminated · Carcinoma, Hepatocellular · study director
- Ph1NCT05652335 · A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisJanssen Research & Development, LLC · recruiting · Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis · study director
- Ph3NCT05572515 · A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph2NCT05564052 · A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell LymphomaJanssen Research & Development, LLC · completed · Lymphoma, Mantle-Cell · study director
- Ph3NCT05552222 · A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph3NCT05550532 · A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyJanssen Research & Development, LLC · completed · Depressive Disorder, Major, Anhedonia · study director
- Ph1NCT05541315 · A Single Ascending Dose Study of JNJ-88260237 in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph3NCT05528510 · A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · active not recruiting · Colitis, Ulcerative · study director
- Ph1NCT05522517 · A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4Janssen Research & Development, LLC · completed · Healthy · study director
- Ph1NCT05521087 · A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasJanssen Research & Development, LLC · withdrawn · Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia · study director
- Ph3NCT05518149 · A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)Janssen Research & Development, LLC · terminated · Depressive Disorder, Major · study director
- N/ANCT05503550 · Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · no longer available · Relapsed or Refractory Multiple Myeloma · study director
- Ph2NCT05498428 · A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerJanssen Research & Development, LLC · recruiting · Carcinoma, Non-small-Cell Lung · study director
- Ph1/Ph2NCT05488314 · A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerJanssen Research & Development, LLC · active not recruiting · Carcinoma, Non-Small-Cell Lung · study director
- N/ANCT05463939 · Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma PatientsJanssen Research & Development, LLC · approved for marketing · Relapsed or Refractory Multiple Myeloma · study director
- Ph3NCT05461209 · A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple MyelomaJanssen Research & Development, LLC · withdrawn · Relapsed/ Refractory Multiple Myeloma · study director
- Ph3NCT05455320 · A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph3NCT05455684 · A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant TherapyJanssen Research & Development, LLC · completed · Depressive Disorder, Major, Anhedonia · study director
- Ph1NCT05453903 · A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed TherapiesJanssen Research & Development, LLC · active not recruiting · Leukemia, Myeloid, Acute · study director
- Ph1NCT05444530 · A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative NeoplasmsJanssen Research & Development, LLC · completed · Myeloproliferative Neoplasms · study director
- Ph1NCT05441501 · A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerJanssen Research & Development, LLC · completed · Prostatic Neoplasms · study director
- Ph3NCT05438043 · A Study of DaratumumabJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph1NCT05424822 · A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)Janssen Research & Development, LLC · active not recruiting · Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell · study director
- Ph1/Ph2NCT05421663 · A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaJanssen Research & Development, LLC · active not recruiting · Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse · study director
- Ph1NCT05407818 · A Study of JNJ-63733657 in Healthy Chinese ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- N/ANCT05401214 · Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)Janssen Research & Development, LLC · approved for marketing · Metastatic Castration-resistant Prostate Cancer · study director
- Ph1NCT05387759 · A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph3NCT05388669 · A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung CancerJanssen Research & Development, LLC · active not recruiting · Advanced or Metastatic Non-small Cell Lung Cancer · study director
- Ph2NCT05379634 · A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesJanssen Research & Development, LLC · completed · Myositis · study director
- Ph1NCT05378906 · A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph1/Ph2NCT05379595 · A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerJanssen Research & Development, LLC · recruiting · Advanced or Metastatic Colorectal Cancer · study director
- Ph2NCT05364554 · A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque PsoriasisJanssen Research & Development, LLC · completed · Plaque Psoriasis · study director
- Ph2NCT05357755 · A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque PsoriasisJanssen Research & Development, LLC · completed · Plaque Psoriasis · study director
- Ph2/Ph3NCT05327114 · Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Janssen Research & Development, LLC · recruiting · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating · study director
- Ph1/Ph2NCT05316155 · Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerJanssen Research & Development, LLC · active not recruiting · Non-Muscle Invasive Bladder Neoplasms · study director
- Ph1NCT05295927 · A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)Janssen Research & Development, LLC · terminated · Prostatic Neoplasms · study director
- Ph2NCT05275023 · An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B ParticipantsJanssen Research & Development, LLC · completed · Hepatitis B, Chronic · study director
- Ph3NCT05272150 · Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp PsoriasisJanssen Research & Development, LLC · completed · Plaque Psoriasis, Scalp Psoriasis · study director
- Ph1NCT05268497 · A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant DepressionJanssen Research & Development, LLC · withdrawn · Depression · study director
- Ph2/Ph3NCT05265273 · A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisJanssen Research & Development, LLC · recruiting · Myasthenia Gravis · study director
- Ph1NCT05252520 · A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese ParticipantsJanssen Research & Development, LLC · withdrawn · Healthy · study director
- Ph1NCT05252533 · A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or PsoriasisJanssen Research & Development, LLC · completed · Juvenile Psoriatic Arthritis, Psoriasis, Arthritis, Juvenile · study director
- Ph2NCT05250973 · A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisJanssen Research & Development, LLC · active not recruiting · Amyloidosis · study director
- Ph2NCT05242484 · A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisJanssen Research & Development, LLC · active not recruiting · Colitis, Ulcerative · study director
- N/ANCT05242458 · A Study of Ustekinumab Treatment in Children With Crohn's DiseaseJanssen Research & Development, LLC · completed · Crohn's Disease · study director
- Ph2NCT05242471 · A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · active not recruiting · Crohn's Disease · study director
- Ph1NCT05236868 · A Study of JNJ-42847922 (Seltorexant) in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT05223868 · A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque PsoriasisJanssen Research & Development, LLC · completed · Plaque Psoriasis · study director
- N/ANCT05221619 · Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)Janssen Research & Development, LLC · temporarily not available · Warm Autoimmune Hemolytic Anemia · study director
- Ph4NCT05201781 · A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelJanssen Research & Development, LLC · recruiting · Multiple Myeloma · study director
- Ph1NCT05201937 · A Study of JNJ-64281802 in Healthy Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT05201794 · A Study of JNJ-64281802 for the Prevention of Dengue InfectionJanssen Research & Development, LLC · terminated · Dengue · study director
- Ph3NCT05197049 · A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · active not recruiting · Crohn Disease · study director
- Ph1NCT05197062 · A Study of 14C JNJ-67953964 in Healthy Adult Male ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- N/ANCT05179460 · A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary RetinopathyJanssen Research & Development, LLC · completed · Pigmentary Maculopathy, Pigmentary Retinopathy, Interstitial Cystitis · study director
- N/ANCT05161598 · Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)Janssen Research & Development, LLC · no longer available · Multiple Myeloma · study director
- Ph1NCT05155007 · A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirJanssen Research & Development, LLC · completed · Healthy · study director
- Ph1NCT05151692 · A Study of JNJ-80202135 in Healthy Chinese Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Early Ph1NCT05148780 · A Study of Acute Respiratory Infections in Global Outpatient SettingJanssen Research & Development, LLC · completed · Acute Respiratory Infection · study director
- Ph1NCT05123599 · A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionJanssen Research & Development, LLC · completed · Hepatitis B, Chronic · study director
- Ph1NCT05112952 · A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937)Janssen Research & Development, LLC · completed · Hepatic Impairment, Healthy · study director
- Ph1NCT05112939 · A Study of a Rilpivirine Extended-Release Suspension in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- N/ANCT05109195 · A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor AntidepressantJanssen Research & Development, LLC · terminated · Depressive Disorder, Major · study director
- Ph1NCT05106153 · A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and ZolpidemJanssen Research & Development, LLC · completed · Healthy Non-dependent, Recreational Sedative Users, Abuse Potential · study director
- Ph3NCT05092269 · A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsJanssen Research & Development, LLC · active not recruiting · Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic · study director
- Ph1NCT05083078 · A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic ArthritisJanssen Research & Development, LLC · terminated · Arthritis, Psoriatic, Healthy · study director
- Ph3NCT05083182 · A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic ArthritisJanssen Research & Development, LLC · completed · Arthritis, Juvenile · study director
- Ph3NCT05083169 · A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph1NCT05076877 · A Study of Lazertinib (JNJ-73841937) in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT05071664 · A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisJanssen Research & Development, LLC · completed · Arthritis, Psoriatic · study director
- Ph1NCT05050097 · A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple MyelomaJanssen Research & Development, LLC · active not recruiting · Multiple Myeloma · study director
- Ph4NCT05029921 · A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's DiseaseJanssen Research & Development, LLC · completed · Crohn Disease · study director
- Ph1NCT05022849 · A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsJanssen Research & Development, LLC · completed · Prostatic Neoplasms · study director
- Ph1NCT05014360 · A Study of JNJ-64251330 in Participants With Familial Adenomatous PolyposisJanssen Research & Development, LLC · completed · Adenomatous Polyposis Coli · study director
- Early Ph1NCT05007756 · A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of InterestJanssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT05005507 · A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus InfectionJanssen Research & Development, LLC · terminated · Hepatitis B, Chronic · study director
- Ph1NCT04991740 · A Study of JNJ-78306358 in Participants With Advanced Stage Solid TumorsJanssen Research & Development, LLC · completed · Neoplasms · study director
- Ph2NCT04991753 · A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid ArthritisJanssen Research & Development, LLC · completed · Arthritis, Rheumatoid · study director
- Ph2NCT04990440 · A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisJanssen Research & Development, LLC · terminated · Dermatitis, Atopic · study director
- Ph3NCT04988295 · A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib FailureJanssen Research & Development, LLC · active not recruiting · Carcinoma, Non-Small-Cell Lung · study director
- Ph2NCT04988308 · A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis SuppurativaJanssen Research & Development, LLC · terminated · Hidradenitis Suppurativa · study director
- Ph1NCT04985812 · A Study of JNJ-67484703 in Participants With Active Rheumatoid ArthritisJanssen Research & Development, LLC · completed · Rheumatoid Arthritis · study director
- Ph1NCT04985955 · A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3Janssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT04978337 · A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) InfectionJanssen Research & Development, LLC · terminated · Respiratory Syncytial Virus · study director
- Ph1NCT04973566 · A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy ParticipantsJanssen Research & Development, LLC · completed · Healthy · study director
- Ph2NCT04968912 · A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)Janssen Research & Development, LLC · completed · Sjogren's Syndrome · study director
- Ph1NCT04963738 · A Study of JNJ-73763989 in Adult Participants With Renal ImpairmentJanssen Research & Development, LLC · completed · Renal Impairment · study director
- Ph1NCT04960124 · A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult ParticipantsJanssen Research & Development, LLC · completed · Healthy, Hepatic Impairment · study director
- Ph1NCT04951609 · A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and PsychotherapyJanssen Research & Development, LLC · terminated · Depressive Disorder, Major · study director
- Ph3NCT04951622 · A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisJanssen Research & Development, LLC · recruiting · Myasthenia Gravis · study director
- N/ANCT04951154 · A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung CancerJanssen Research & Development, LLC · completed · Carcinoma, Non-Small-Cell Lung · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.